Gilead Sciences completes purchase of MYR GmbH for 1.45 billion Euros Ruchika Sharma7 March 2021 10:00 AM ISTFoster City: Gilead Sciences, Inc. has recently announced the completion of the previously announced transaction to acquire MYR GmbH for up to...
Gilead remdesivir not associated with kidney problems in COVID-19 patients: European panel Ruchika Sharma14 Feb 2021 10:00 AM ISTNew Delhi: Europe's drugs regulator said on Friday its safety panel found no evidence that Gilead's remdesivir caused kidney problems in some COVID-19...
Gilead remdesivir suspended by WHO from prequalification list of COVID-19 drugs Ruchika Sharma21 Nov 2020 1:41 PM ISTNew Delhi: The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official...
Antiviral drug remdesivir should not be used to treat Covid patients, warns WHO MD Bureau20 Nov 2020 1:15 PM ISTGeneva: The World Health Organization (WHO) on Friday warned that the antiviral drug remdesivir should not be used to treat Covid-19 patients no...
Cipla says demand for Covid antiviral drug remdesivir rising sharply in India Ruchika Sharma10 Nov 2020 11:46 AM ISTRemdesivir has become the standard of care for patients hospitalised with severe Covid-19, with more than 50 countries including the United States...
Russian firm Pharmasyntez seeks to produce COVID drug remdesivir without patent: Report Ruchika Sharma3 Nov 2020 12:36 PM ISTThe Russian firm has completed a clinical trial of the generic drug, labelled Remdeform, on 300 patients across 23 Russian hospitals, a register entry...
Nations mulling Gilead COVID drug Remdesivir should consider trial failure before showing green flag: WHO scientist Farhat Nasim25 Oct 2020 11:00 AM ISTGeneva: Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a trial in which the...
Mexico will not follow USFDA in approving Gilead COVID-19 drug: Report Ruchika Sharma25 Oct 2020 10:15 AM ISTMexico City: Mexico will not necessarily follow the U.S. Food and Drug Administration (FDA) in approving Gilead Science Inc's antiviral drug...
FDA approves remdesivir for treating hospitalized COVID-19 patients Dr. Kamal Kant Kohli23 Oct 2020 4:50 AM ISTThe US Food and drug administration has approved the antiviral drug remdesivir for treating hospitalized COVID-19 patients—adults and children ages 12...
Gilead contests WHO study claiming Covid drug Remdesivir Failed to Reduce Mortality Ruchika Sharma17 Oct 2020 9:30 AM ISTUS: Gilead Sciences Inc has questioned the findings of a World Health Organization (WHO) study that concluded its Covid-19 drug remdesivir does not...
Gilead, European Commission ink pact for 500000 treatment courses of Remdesivir against COVID-19 MD Bureau10 Oct 2020 10:00 AM ISTAt this stage, Remdesivir is the only medicine with a conditional marketing authorisation in the EU for the treatment of COVID-19 patients needing...
Gilead to acquire Immunomedics for over USD 20 billion Ruchika Sharma14 Sept 2020 4:25 PM ISTUS: Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion in a deal that would...
